Moreover, PHF6 mutations tend to occur late in the course of myeloid neoplasms, either concurrently with or subsequently to SF3B1 mutations in all cases, and are associated with disease progression in a subset of the cases. This evidence concerns the gene SF3B1 and myeloid neoplasm.